Topics

French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A

11:24 EDT 10 Jul 2019 | Labiotech.eu

The French biotech Osivax has advanced in the race to develop a universal flu vaccine, raising €8M to achieve clinical proof-of-concept. Osivax will use most of the funding to progress its lead candidate vaccine towards market approval. Targeting all strains of influenza A viruses, the vaccine is currently in a phase I trial, with results […]

The post French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A appeared first on Labiotech.eu.

Original Article: French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A

NEXT ARTICLE

More From BioPortfolio on "French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...